For decades, India’s high-end medical device market has been dominated by imports, making advanced diagnostics like MRIs and CT scans expensive and inaccessible for many. Sequoia Healthcare is on a mission to change that.

This isn’t just another distributor. Sequoia is a “Make in India” powerhouse, designing and manufacturing its own advanced CT, MRI, and PET-CT scanners. By targeting a market that is 75-80% dependent on imports, Sequoia is creating a structural advantage that could revolutionize healthcare affordability in India.

The Massive Opportunity in Plain Sight

The growth story here isn’t just a projection; it’s a visible, critical need. India is one of the most under-penetrated markets for advanced diagnostics. The gap between what we need and what we have is staggering.

• MRI Scanners: India needs 15,000 units but has only 3,000.
• CT Scanners: India needs 45,000 units but has only 15,000.

Sequoia is perfectly positioned to capture this massive, underserved market.

Why Hospitals Are Making the Switch?

For a hospital or diagnostic center, a CT or MRI machine is a major capital investment. Sequoia’s value proposition is simple and powerful, attacking the two biggest pain points for buyers: cost and downtime.

✅ 30-40% Lower Purchase Cost By manufacturing in India, Sequoia’s machines are 30-40% cheaper than their imported counterparts, making advanced technology accessible to Tier-2 and Tier-3 cities.

✅ Lower Running Costs (The “Helium-Free” Advantage) Sequoia’s flagship 1.5T MRI is helium-free. This is a game-changer. Traditional MRIs require expensive, liquid helium for cooling, which needs periodic refills and carries the risk of a “quench” (sudden helium loss). Sequoia’s design eliminates this cost, reducing the machine’s lifetime running expense and consumables.

✅ Higher Uptime (Service is King) A machine that’s down isn’t making money. Sequoia has a pan-India service network for rapid installation and maintenance. They also provide remote monitoring and predictive support to fix issues before they even happens under a separate, clean structure.

The Growth Engine is Just Getting Started

Sequoia is aggressively scaling to meet demand. Its growth visibility is backed by clear, tangible assets:

• New Factory: A new, state-of-the-art manufacturing facility in AMTZ, Vishakhapatnam, is ramping up capacity.
• Expanding Portfolio: The company is moving up the value chain, with 3.0T MRIs, 128-slice CTs, Cardiac CTs, and Digital PET-CT scanners all in the pipeline.
• Recurring Revenue: The services, repairs, and spare parts business creates a sticky, high-margin, recurring revenue stream that grows with every new machine sold.

Financial Analysis

📊 Sequoia’s Growth Plan: The Numbers

Sequoia’s financial plan shows how they expect to grow from a small company into a major player. The numbers from FY23 and FY24 are Actual (A)—what really happened. FY25 is a Projection (P) based on the current year, and the later years are Estimates (E).

The most exciting part is the huge leap in growth they expect, especially starting in FY27.

Why Should We Trust These Big Projections?

A sudden 128% jump in revenue (like in FY27) can look like a wild guess. But in Sequoia’s case, these estimates are based on real, funded projects that are already in motion.

1. The New Factory is a Game-Changer That massive 128% revenue jump planned for FY27 isn’t just a number. It’s the direct result of their brand new, state-of-the-art factory in AMTZ, Vishakhapatnam, coming online. This new plant means they can physically build and sell a lot more machines to meet the huge, unfulfilled demand in India.

2. They Are Selling More of Their Own Profitable Stuff Look at the profit margins (PAT %)—they are set to get better every single year. This is because the company is changing what it sells. In the past, a lot of revenue came from lower-profit servicing. The future growth is all about selling their high-profit “Own Brand” machines. Selling their own products makes them much more money on each sale.

3. They Are Making Newer, Fancier Machines Sequoia isn’t just selling more machines; they are starting to sell better (and more expensive) ones. They are adding new, high-tech models to their lineup, like the 3.0 Tesla MRI and 128-slice CT scanners. These advanced machines cost more, which helps push their revenue numbers up and opens the door to bigger hospitals.

Peer Analysis: A “Make in India” Med-Tech

Finding a perfect listed peer for Sequoia is difficult, as the high-end MRI/CT space is dominated by unlisted global giants (GE, Siemens, Philips). Therefore, we must compare it to other successful, listed Indian med-tech manufacturers.

Hemant Surgical and Holmarc Opto-Mechatronics are two such “Make in India” medical equipment companies with a similar small-cap profile.

Analysis: This comparison shows that Sequoia is valued very attractively.

Valuation Discount: Sequoia trades at a significantly lower P/E ratio (~13.7x) compared to its peers (17.5x – 31x). This is despite having a arguably larger addressable market (high-end radiology vs. surgical instruments/optics) and a clearer, explosive projection for revenue growth (128% in FY27E).

Strong Profitability: Its projected 10.3% PAT margin is highly competitive and in line with other efficient domestic manufacturers.

The Valuation Snapshot: An Opportunity?

Price (Approx): ₹163 Market Cap (Approx): ₹110 Cr

At its current market cap, Sequoia appears to be trading at a significant discount to its growth potential.

• On FY25 (Actual Profit): The stock trades at just 13.7x P/E (on ₹8 Cr PAT).
• On FY26 (Projected Profit): The multiple compresses to a mere 8.4x P/E (on ₹13 Cr PAT).
• On FY27 (Projected Profit): This falls to an incredibly low 3.2x P/E (on ₹34 Cr PAT).

This is a fraction of the 25x-50x P/E multiples that listed diagnostics and med-tech platforms command. Sequoia offers investors a rare combination: a business with a strong domestic manufacturing tailwind, a massive underserved market, and a financial profile that is set to re-rate significantly as its profitability scales.

Looking to invest in more high-potential companies like Sequoia Healthcare ?
Explore exclusive opportunities by logging in to Altius Investech today!

GET IN TOUCH WITH US:

For any query/ personal assistance feel free to reach out at support@Altiusinvestech.com or call us at +91-8240614850.
Learn, more about Unlisted Company.

Join our Whatsapp Channel: The Market Buzz by Altius

📜 Disclaimer

(Data as of July 29th, 2025, from public sources & altiusinvestech.com. For educational purposes only; not investment advice. Altius Investech is not SEBI-registered; investors should do their own due diligence.)